How Employees Make a Difference at Illumina
NORTHAMPTON, MA / ACCESSWIRE / August 2, 2024 / What if one thing could change everything for the better? That's genomics. At Illumina, our vision for the future includes accessibility to genome sequencing, personalized medicine, and more positive outcomes for those facing disease. Our employees have found careers where their individual contributions are amplified into world-changing impacts. Hear first-hand what it's like to work in genomics at Illumina. Watch the series here.
A global genomics leader, Illumina develops DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health. Our products help pioneer advances in oncology, genetic and infectious diseases, reproductive health, and beyond. Our technology empowers continued innovation towards positive and impactful people- and planet-healing solutions. Learn more about working at Illumina and how we are making an impact.
View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com.
Contact Info:
Spokesperson: Illumina
Website: https://www.3blmedia.com/profiles/illumina
Email: info@3blmedia.com
SOURCE: Illumina
View the original press release on accesswire.com
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
New 4-Star Stocks
-
Morningstar’s Guide to Investing in Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage